用天然产品治疗:胡说八道还是可能?
Milan Malaník1, Marie Čulenová1, Alice Sychrová1
1Department of Natural Drugs, Faculty of Pharmacy, Masaryk University, Palackého 1946/1, 61200 Brno, Czech Republic.
Pharmaceuticals (Basel, Switzerland)
|August 26, 2023
概括
来自植物的天然化合物显示出作为抗治疗的抗药物有前途. 本次审查强调了来自植物的有希望的治疗候选药物,为当前的抗药物提供了可访问和具有成本效益的替代品.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 植物化学 植物化学
背景情况:
- 是一种神经系统疾病,会导致经常性发作.
- 目前的抗药物 (AED) 是有效的,但可访问性和成本仍然是挑战.
- 植物衍生化合物为新的,具有成本效益的治疗提供了潜在的潜力.
研究的目的:
- 在临床前模型中审查具有已证明抗活性的天然化合物.
- 为了确定有前途的植物性治疗的候选药物.
- 根据现有的临床数据和药物动力学特性,评估这些化合物的潜力.
主要方法:
- 对具有抗作用的天然化合物进行系统的文献搜索.
- 包括使用相关剂量的体内模型的研究.
- 对具有证实临床数据的化合物的分析.
- 化合物的分子标的分类.
- 对数据,药物动力学特性和潜在相互作用进行批判性评估.
主要成果:
- 确定了几种具有显著抗活性的天然化合物.
- 在表格中总结了发现,详细介绍了分子点.
- 突出的化合物具有有前途的治疗潜力,由药理动力学数据支持.
- 已知实例中,疗效得到了临床证据的证实.
结论:
- 来自植物的天然化合物代表了开发新抗疗法的可行途径.
- 对这些化合物的进一步研究可以导致更容易获得和更具成本效益的治疗.
- 本综述为未来对和相关神经系统疾病的植物疗法的研究提供了基础.
相关概念视频
Arteries of the Lower Limbs
213
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
213
Antiepileptic Drugs: Glutamate Antagonists
421
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
421
Antiepileptic Drugs: GABAergic Pathway Potentiators
460
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
460
Antiepileptic Drugs: Sodium Channel Blockers
664
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
664
Antiepileptic Drugs: Calcium Channel Blockers
453
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
453
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
344
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
344


